Genetic Discovery in Rare Diseases pilot grant awardees announced
New Mice Enable CRISPR-based Epigenome Editing in Living Animals
A CRISPR-Cas9 variant with deactivated DNA-cutting function – known as “dCas9” - is a powerful tool to help researchers understand what genes do when their expression is dialed up or down, but it has some limitations.
Children With Mild or Asymptomatic COVID Have Strong Antibodies Months Later
Sandeep Dave featured in Magnify: Getting Personal with Blood Cancers
Metabolomics Lab's Analysis Finds Near-meat and Meat Not Nutritionally Equivalent
Bringing Back Helpful Gut Worms
William Parker, associate professor of surgery at Duke University School of Medicine, was a guest on Constant Wonder, a podcast from BYU Radio. He discussed intestinal worms and how not all bacteria is harmful; some may actually help us.
Cancer treatment startup started by Duke faculty raises $70M
Cerebral Cavernous Malformation: Moving Away From Surgery, Exploring Alternate Treatments
In a paper published in Nature, a cancer-like mutation was linked to cerebral cavernous malformations (CCMs), a condition in which blood vessels in the brain are formed abnormally. Currently, the condition can only be treated by means of surgery however the discovery of the mutation has the potential to develop novel therapeutic strategies.
Congratulations Distinguished Professors!
Precision Genomics Collaboratory Newsletter: Vol 1 Issue 2
This issue includes
- Funding opportunities from the Precision Genomics Collaboratory
- News updates from the genomics community
- Featured publications
- Duke funding opportunities of potential interest
- Upcoming events